BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37670477)

  • 21. Administration of Steamed and Freeze-Dried Mature Silkworm Larval Powder Prevents Hepatic Fibrosis and Hepatocellular Carcinogenesis by Blocking TGF-β/STAT3 Signaling Cascades in Rats.
    Lee DY; Yun SM; Song MY; Ji SD; Son JG; Kim EH
    Cells; 2020 Feb; 9(3):. PubMed ID: 32121064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of SOCS1 and SOCS3 tumor suppressors and oncogenic signaling pathway genes in hepatocellular carcinoma.
    Khan MGM; Ghosh A; Variya B; Santharam MA; Ihsan AU; Ramanathan S; Ilangumaran S
    BMC Cancer; 2020 Aug; 20(1):774. PubMed ID: 32807134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma.
    Chen S; Zheng P; Wang W; Yi M; Chen P; Cai J; Li J; Peng Q; Ban Y; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Xiang B
    J Cell Physiol; 2018 Jun; 233(6):5002-5013. PubMed ID: 29227538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.
    Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N
    J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CTGF Mediates Tumor-Stroma Interactions between Hepatoma Cells and Hepatic Stellate Cells to Accelerate HCC Progression.
    Makino Y; Hikita H; Kodama T; Shigekawa M; Yamada R; Sakamori R; Eguchi H; Morii E; Yokoi H; Mukoyama M; Hiroshi S; Tatsumi T; Takehara T
    Cancer Res; 2018 Sep; 78(17):4902-4914. PubMed ID: 29967264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma.
    Tan W; Luo X; Li W; Zhong J; Cao J; Zhu S; Chen X; Zhou R; Shang C; Chen Y
    EBioMedicine; 2019 Feb; 40():446-456. PubMed ID: 30594557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylation of NF-κBp65 drives inflammation-mediated hepatocellular carcinogenesis and is a novel therapeutic target.
    Xu X; Lei Y; Chen L; Zhou H; Liu H; Jiang J; Yang Y; Wu B
    J Exp Clin Cancer Res; 2021 Aug; 40(1):253. PubMed ID: 34380537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Silybum marianum total extract, silymarin and silibinin abate hepatocarcinogenesis and hepatocellular carcinoma growth via modulation of the HGF/c-Met, Wnt/β-catenin, and PI3K/Akt/mTOR signaling pathways.
    Yassin NYS; AbouZid SF; El-Kalaawy AM; Ali TM; Almehmadi MM; Ahmed OM
    Biomed Pharmacother; 2022 Jan; 145():112409. PubMed ID: 34781148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B virus X protein enhances the development of liver fibrosis and the expression of genes associated with epithelial-mesenchymal transitions and tumor progenitor cells.
    Ahodantin J; Lekbaby B; Bou Nader M; Soussan P; Kremsdorf D
    Carcinogenesis; 2020 May; 41(3):358-367. PubMed ID: 31175830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multigenerational maternal obesity increases the incidence of HCC in offspring via miR-27a-3p.
    Sun Y; Wang Q; Zhang Y; Geng M; Wei Y; Liu Y; Liu S; Petersen RB; Yue J; Huang K; Zheng L
    J Hepatol; 2020 Sep; 73(3):603-615. PubMed ID: 32593682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zinc fingers and homeoboxes 2 is required for diethylnitrosamine-induced liver tumor formation in C57BL/6 mice.
    Jiang J; Turpin C; Qiu GS; Xu M; Lee E; Hinds TD; Peterson ML; Spear BT
    Hepatol Commun; 2022 Dec; 6(12):3550-3562. PubMed ID: 36194180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PTTG1 is involved in TNF-α-related hepatocellular carcinoma via the induction of c-myc.
    Lin X; Yang Y; Guo Y; Liu H; Jiang J; Zheng F; Wu B
    Cancer Med; 2019 Sep; 8(12):5702-5715. PubMed ID: 31385458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [E26 transformation-specific variant 4 promotes sorafenib and cisplatin resistance in hepatocellular carcinoma cells
    Xiaohui C; Xin LI; Dehua WU
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Aug; 39(8):875-882. PubMed ID: 31511205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer.
    Schneider C; Teufel A; Yevsa T; Staib F; Hohmeyer A; Walenda G; Zimmermann HW; Vucur M; Huss S; Gassler N; Wasmuth HE; Lira SA; Zender L; Luedde T; Trautwein C; Tacke F
    Gut; 2012 Dec; 61(12):1733-43. PubMed ID: 22267597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. β-Arrestin1 enhances hepatocellular carcinogenesis through inflammation-mediated Akt signalling.
    Yang Y; Guo Y; Tan S; Ke B; Tao J; Liu H; Jiang J; Chen J; Chen G; Wu B
    Nat Commun; 2015 Jun; 6():7369. PubMed ID: 26077142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer.
    Aytes A; Mitrofanova A; Kinkade CW; Lefebvre C; Lei M; Phelan V; LeKaye HC; Koutcher JA; Cardiff RD; Califano A; Shen MM; Abate-Shen C
    Proc Natl Acad Sci U S A; 2013 Sep; 110(37):E3506-15. PubMed ID: 23918374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4
    Mossanen JC; Kohlhepp M; Wehr A; Krenkel O; Liepelt A; Roeth AA; Möckel D; Heymann F; Lammers T; Gassler N; Hermann J; Jankowski J; Neumann UP; Luedde T; Trautwein C; Tacke F
    Gastroenterology; 2019 May; 156(6):1877-1889.e4. PubMed ID: 30710528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The hepatic senescence-associated secretory phenotype promotes hepatocarcinogenesis through Bcl3-dependent activation of macrophages.
    Huang Y; Yang X; Meng Y; Shao C; Liao J; Li F; Li R; Jing Y; Huang A
    Cell Biosci; 2021 Sep; 11(1):173. PubMed ID: 34530917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic NOD2 promotes hepatocarcinogenesis via a RIP2-mediated proinflammatory response and a novel nuclear autophagy-mediated DNA damage mechanism.
    Zhou Y; Hu L; Tang W; Li D; Ma L; Liu H; Zhang S; Zhang X; Dong L; Shen X; Chen S; Xue R; Zhang S
    J Hematol Oncol; 2021 Jan; 14(1):9. PubMed ID: 33413510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional machinery of TNF-α-inducible YTH domain containing 2 (YTHDC2) gene.
    Tanabe A; Konno J; Tanikawa K; Sahara H
    Gene; 2014 Feb; 535(1):24-32. PubMed ID: 24269672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.